Lisdexamfetamine dimesylate is the generic ingredient in one branded drug marketed by Takeda Pharms Usa and is included in two NDAs. There are nineteen patents protecting this compound.
Drug patent litigation for LISDEXAMFETAMINE DIMESYLATE.
This ingredient has one hundred and forty-four patent family members in twenty-seven countries.
One supplier is listed for this compound. There are six tentative approvals for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
